Clinical trials
Recruiting Liver Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
| 89bio, Inc. | 2 |
| University of Chicago | 2 |
| Alnylam Pharmaceuticals | 1 |
| Arbor Research Collaborative for Health | 1 |
| AusperBio Therapeutics Inc. | 1 |
| Baylor College of Medicine | 1 |
| Deciphera Pharmaceuticals, LLC | 1 |
| Duke University | 1 |
| Eccogene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Diseases | 33 |
| Fibrosis | 8 |
| Non-alcoholic Fatty Liver Disease | 5 |
| Fatty Liver | 4 |
| Liver Cirrhosis | 4 |
| Metabolic Diseases | 4 |
| Obesity | 4 |
| Diabetes Mellitus | 3 |
| Digestive System Diseases | 3 |
| Hepatitis B | 3 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.